|
O.A. Polyakova, Yu.M. Tkachenko, O.D. Ostroumova
Relationship between non-alcoholic fatty liver disease and cardiovascular disease: focus on the use of ursodeoxycholic acid
|
№1-2 / 2023
|
|
O.A. Polyakova, L.D. Kozgunova, O.D. Ostroumova
Metabolically associated fatty liver disease: the role of ademetionine
|
№1-2 / 2023
|
|
L.V. Tarasova (1, 2, 3), Yu.V. Tsyganova (3), E.I. Busalaeva (3, 4), O.L. Aryamkina (1)
Analysis of the methods of treatment of non-alcoholic fatty liver disease: focus on innovations
|
№2 / 2019
|
|
E.V. Balukova (1), N.V. Baryshnikova (1), L.N. Belousova (2)
NONALCOHOLIC FATTY LIVER DISEASE: CURRENT STATE OF PROBLEM
|
№2 / 2016
|
|
Ye.V. Golovanova
Thiogamma In Nonalcoholic Fatty Liver Disease
|
№7 / 2012
|
|
L.A. Zvenigorodskaya, E.A. Cherkashova, N.G. Samsonova
Hepatoprotectors In The Treatment Of Nonalcoholic Fatty Liver Disease
|
№15 / 2011
|
|
I.V. Mayev, V.V. Tsukanov, Ye.V.Lukicheva, A.A. Samsonov, A.V. Vasyutin, I.N. Nikushkina
Prevalence, Pathogenesis And Principles Of Treatment Nonalcoholic Fatty Liver Disease
|
№12 / 2011
|
|
O. Drapkina, D.Tutnov
Certain Aspects Of Diagnostics And Treatment Of Cardiovascular Diseases In Combination With Non-alcoholic Steatohepatitis
|
№5 / 2010
|
Русский
